Market View

The U.S. market was shifted to a Confirmed Uptrend. Each index staged a follow-through day after posting strong weekly gains.
The S&P 500 has regained its 50-DMA (5,464) and is testing price resistance along ~5,566. The Nasdaq is slightly above its 50-DMA
(17,585) and attempting to settle above this key moving average. No distribution days on either index.

O’Neil Health Care Weekly

XLV advanced 60bps last week, remaining at all-time highs with a sharply rising RS line. Though we expect the sector to pullback given broad market weakness, we believe it will continue to outperform the market, warranting an overweight sector positioning. Look for immediate support at its 21-DMA ($148.76), followed by the 50-DMA ($146.62).

Market View

The U.S. market is in a Downtrend. Indices declined 2-3% due to broad-based distribution. The S&P 500 is testing 100-DMA (5,307) support while the Nasdaq breached its 100-DMA (16,878) and is testing price support along ~16,500, which coincides with the top of the prior base. Stay patient and wait for indices to settle and attempt a new rally.

O’Neil Health Care Weekly

XLV rallied further into all-time highs early last week, but ended the week down 27bps after a sharp pullback on Thursday to 21-DMA ($146.79) support. Its RS line continues to rise from lows, warranting an equal-weight sector positioning.

Market View

The U.S. market was shifted to an Uptrend Under Pressure. The S&P 500 and Nasdaq declined 1.9% and 3.6%, respectively, with each index closing below its 21-DMA (5,533 ,18,002). The next level of support it the rising 50-DMA (5,410;17,422), which is ~2% lower. The distribution day stands at five and four, respectively, with one day expiring on each index at the end of next week.